KRW 20450.0
(0.74%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 352.34 Billion KRW | 10.91% |
2022 | 317.68 Billion KRW | 27.5% |
2021 | 249.15 Billion KRW | -1.56% |
2020 | 253.09 Billion KRW | 1.26% |
2019 | 249.94 Billion KRW | -12.93% |
2018 | 287.04 Billion KRW | 15.26% |
2017 | 249.04 Billion KRW | 12.47% |
2016 | 221.44 Billion KRW | 20.04% |
2015 | 184.47 Billion KRW | 16.6% |
2014 | 158.2 Billion KRW | 3.03% |
2013 | 153.55 Billion KRW | 227.86% |
2012 | 46.83 Billion KRW | 30.16% |
2011 | 35.98 Billion KRW | -67.21% |
2010 | 109.73 Billion KRW | 2.97% |
2009 | 106.56 Billion KRW | 6.11% |
2008 | 100.42 Billion KRW | 31.99% |
2007 | 76.08 Billion KRW | 59.28% |
2006 | 47.76 Billion KRW | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 370.29 Billion KRW | 5.09% |
2024 Q2 | 375.45 Billion KRW | 1.39% |
2023 Q3 | 348.5 Billion KRW | 3.06% |
2023 FY | 352.34 Billion KRW | 10.91% |
2023 Q1 | 336.85 Billion KRW | 6.04% |
2023 Q2 | 338.16 Billion KRW | 0.39% |
2023 Q4 | 352.34 Billion KRW | 1.1% |
2022 Q4 | 317.68 Billion KRW | 0.93% |
2022 Q1 | 261.74 Billion KRW | 5.05% |
2022 Q2 | 288 Billion KRW | 10.03% |
2022 FY | 317.68 Billion KRW | 27.5% |
2022 Q3 | 314.76 Billion KRW | 9.29% |
2021 Q2 | 256.74 Billion KRW | -0.75% |
2021 Q1 | 258.69 Billion KRW | 2.21% |
2021 Q3 | 253.89 Billion KRW | -1.11% |
2021 Q4 | 249.15 Billion KRW | -1.87% |
2021 FY | 249.15 Billion KRW | -1.56% |
2020 Q3 | 256.89 Billion KRW | -4.34% |
2020 FY | 253.09 Billion KRW | 1.26% |
2020 Q2 | 268.54 Billion KRW | 1.97% |
2020 Q1 | 263.36 Billion KRW | 5.37% |
2020 Q4 | 253.09 Billion KRW | -1.48% |
2019 Q1 | 277.78 Billion KRW | -3.23% |
2019 Q2 | 260.2 Billion KRW | -6.33% |
2019 Q4 | 249.94 Billion KRW | -2.26% |
2019 Q3 | 255.71 Billion KRW | -1.73% |
2019 FY | 249.94 Billion KRW | -12.93% |
2018 FY | 287.04 Billion KRW | 15.26% |
2018 Q4 | 287.04 Billion KRW | -7.21% |
2018 Q3 | 309.35 Billion KRW | 7.42% |
2018 Q2 | 287.97 Billion KRW | 8.52% |
2018 Q1 | 265.35 Billion KRW | 6.55% |
2017 FY | 249.04 Billion KRW | 12.47% |
2017 Q2 | 230.39 Billion KRW | 1.82% |
2017 Q3 | 236.2 Billion KRW | 2.52% |
2017 Q4 | 249.04 Billion KRW | 5.44% |
2017 Q1 | 226.26 Billion KRW | 2.18% |
2016 Q2 | 207.16 Billion KRW | 19.68% |
2016 Q4 | 221.44 Billion KRW | -0.79% |
2016 Q3 | 223.19 Billion KRW | 7.74% |
2016 FY | 221.44 Billion KRW | 20.04% |
2016 Q1 | 173.09 Billion KRW | -6.17% |
2015 Q4 | 184.47 Billion KRW | -3.59% |
2015 FY | 184.47 Billion KRW | 16.6% |
2015 Q1 | 165.1 Billion KRW | 4.36% |
2015 Q2 | 173.02 Billion KRW | 4.8% |
2015 Q3 | 191.34 Billion KRW | 10.59% |
2014 Q4 | 158.2 Billion KRW | -3.34% |
2014 Q3 | 163.67 Billion KRW | 2.16% |
2014 Q2 | 160.21 Billion KRW | 3.37% |
2014 FY | 158.2 Billion KRW | 3.03% |
2014 Q1 | 155 Billion KRW | 0.94% |
2013 Q1 | 126.81 Billion KRW | 170.76% |
2013 Q3 | 137.21 Billion KRW | 4.31% |
2013 Q4 | 153.55 Billion KRW | 11.9% |
2013 FY | 153.55 Billion KRW | 227.86% |
2013 Q2 | 131.55 Billion KRW | 3.74% |
2012 Q4 | 46.83 Billion KRW | 0.0% |
2012 FY | 46.83 Billion KRW | 30.16% |
2012 Q1 | 58.24 Million KRW | 0.0% |
2011 FY | 35.98 Billion KRW | -67.21% |
2011 Q1 | - KRW | 0.0% |
2011 Q3 | 57.37 Million KRW | -82.15% |
2011 Q2 | 321.4 Million KRW | 0.0% |
2010 FY | 109.73 Billion KRW | 2.97% |
2010 Q2 | 9.15 Million KRW | 0.0% |
2010 Q3 | - KRW | -100.0% |
2009 Q2 | - KRW | 0.0% |
2009 Q3 | - KRW | 0.0% |
2009 Q4 | - KRW | 0.0% |
2009 FY | 106.56 Billion KRW | 6.11% |
2008 Q2 | 111.65 Million KRW | 0.0% |
2008 Q4 | 1.72 Billion KRW | -0.55% |
2008 Q3 | 1.73 Billion KRW | 1449.96% |
2008 FY | 100.42 Billion KRW | 31.99% |
2007 Q4 | - KRW | 0.0% |
2007 Q2 | - KRW | 0.0% |
2007 FY | 76.08 Billion KRW | 59.28% |
2007 Q3 | - KRW | 0.0% |
2006 FY | 47.76 Billion KRW | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
PharmGen Science, Inc. | 20.71 Billion KRW | -1601.077% |
Wooridul Huebrain Limited | 9.23 Billion KRW | -3714.74% |